PL2262535T3 - Zastosowanie kompozycji zawierającej ziemię leczniczą jako leku zobojętniającego kwas - Google Patents

Zastosowanie kompozycji zawierającej ziemię leczniczą jako leku zobojętniającego kwas

Info

Publication number
PL2262535T3
PL2262535T3 PL09732467T PL09732467T PL2262535T3 PL 2262535 T3 PL2262535 T3 PL 2262535T3 PL 09732467 T PL09732467 T PL 09732467T PL 09732467 T PL09732467 T PL 09732467T PL 2262535 T3 PL2262535 T3 PL 2262535T3
Authority
PL
Poland
Prior art keywords
antacid
composition containing
healing earth
containing healing
earth
Prior art date
Application number
PL09732467T
Other languages
English (en)
Inventor
Anna-Maria Westweber
Andreas Schülter
Hans-Georg Hoffmann
Original Assignee
Maria Clementine Martin Klosterfrau Vertriebsges Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Clementine Martin Klosterfrau Vertriebsges Mbh filed Critical Maria Clementine Martin Klosterfrau Vertriebsges Mbh
Publication of PL2262535T3 publication Critical patent/PL2262535T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL09732467T 2008-04-16 2009-02-05 Zastosowanie kompozycji zawierającej ziemię leczniczą jako leku zobojętniającego kwas PL2262535T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008019339A DE102008019339A1 (de) 2008-04-16 2008-04-16 Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
PCT/EP2009/000794 WO2009127283A1 (de) 2008-04-16 2009-02-05 Verwendung einer heilerde-enthaltenden zusammensetzung als antazidum
EP09732467.7A EP2262535B1 (de) 2008-04-16 2009-02-05 Verwendung einer heilerde-enthaltenden zusammensetzung als antazidum

Publications (1)

Publication Number Publication Date
PL2262535T3 true PL2262535T3 (pl) 2013-12-31

Family

ID=39688664

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09732467T PL2262535T3 (pl) 2008-04-16 2009-02-05 Zastosowanie kompozycji zawierającej ziemię leczniczą jako leku zobojętniającego kwas

Country Status (4)

Country Link
EP (1) EP2262535B1 (pl)
DE (2) DE102008019339A1 (pl)
PL (1) PL2262535T3 (pl)
WO (1) WO2009127283A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0807621D0 (en) 2008-04-25 2008-06-04 Ineos Healthcare Ltd Use
EP2654673A1 (en) 2010-12-23 2013-10-30 Colgate-Palmolive Company Fluid compositions comprising a structuring agent
JP2014520865A (ja) * 2011-07-15 2014-08-25 ユーファーマ プロプライエタリー リミテッド 制酸剤、麻酔薬、ならびに二酸化ケイ素と二酸化チタンとを含んでなる無機マトリックスを含んでなる経口用組成物
CN107648070A (zh) 2011-12-15 2018-02-02 高露洁-棕榄公司 水性口腔护理组合物
DE102012014848A1 (de) 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
DE102014103832A1 (de) * 2014-02-13 2015-08-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669822B1 (fr) * 1990-12-03 1993-11-19 Fabre Medicament Pierre Composition pharmaceutique a base d'acide alginique se presentant sous forme d'une mousse.
FR2674437B1 (fr) * 1991-03-29 1993-07-09 Pf Medicament Composition pharmaceutique, utile notamment dans le traitement d'affections gastro-óoesophagiennes.
CA2166731A1 (en) * 1993-07-06 1995-01-19 Robert T. Sims H2 antagonist-alginate-antacid combinations
US5914135A (en) * 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
AR056062A1 (es) * 2006-06-05 2007-09-19 Bago Sa Labor Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion

Also Published As

Publication number Publication date
EP2262535A1 (de) 2010-12-22
DE102008019339A1 (de) 2009-10-22
WO2009127283A1 (de) 2009-10-22
EP2262535B1 (de) 2013-07-10
DE202008006245U1 (de) 2008-08-14

Similar Documents

Publication Publication Date Title
HK1253355B (zh) 含有馬西替坦的治療組合物
ZA201200054B (en) Therapeutic compounds and compositions
EP2364161A4 (en) COMPOSITIONS CONTAINING SATIOGENES AND METHODS OF USE
HK1172326A1 (en) Compounds and compositions and methods of use
PT2475352E (pt) Composição contendo palmitoiletanolamida ultramicronizada
EP2236149A4 (en) MEDICAL COMPOSITION
ZA201106703B (en) Use of pharmaceutical compositions containing mesembrenone
HK1179514A1 (en) Composition for external use
GB0821532D0 (en) Medical adhesive compositions
GB0808835D0 (en) Therapeutic compositions
HK1160925A1 (zh) 組織蛋白酶 的用途
PL2262535T3 (pl) Zastosowanie kompozycji zawierającej ziemię leczniczą jako leku zobojętniającego kwas
EP2277494A4 (en) AUTO-NEUTRALIZING TYPE OF CALCIUM HYDROXIDE PREPARATION FOR USE IN DENTISTRY
GB0819958D0 (en) Therapeutic compositions
IL213711A0 (en) Pharmaceuticl formulation of nanonised fenofibrate
HK1138508A1 (en) Composition for external application to skin
HK1156250A1 (en) Unit dosage of apadenoson
EP2221040A4 (en) COMPOSITION FOR TOPICAL APPLICATION TO THE SKIN
GB0814296D0 (en) Improvements to coffins
EP2298294A4 (en) ANALGESIC / ANTIPRURIGINOUS PREPARATION CONTAINING OXYBUPROCAIN FOR EXTERNAL APPLICATION
EP2514440A4 (en) TRANSDERMAL PREPARATION WITH A BASIC INFLAMMATORY MEDIUM
EP2508164A4 (en) COMPOSITION FOR TEETH
HK1137331A1 (en) Composition for external application to skin
GB0819960D0 (en) Therapeutic composition